Acro Biomedical Co., Ltd. (6748)
Market Closed
16 Oct, 05:30 AM
TWSE 
JPX Primary TWSE NT$
194. 50
-2
-1.0178%
NT$
- Market Cap
- P/E Ratio
80% Div Yield
236,860 Volume
- Eps
NT$ 196.5
Previous Close Want to track 6748 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Acro Biomedical Co., Ltd. (6748) Statistics
Valuation metrics
Market Cap -
Enterprise value 14.75B
Trailing P/E (ttm) -119.66
Forward P/E -
PEG ratio 9.64
Price/Sales (ttm) 191.69
Price/Book (mrq) 14.36
Enterprise Value/Revenue 186.43
Enterprise Value/EBITDA -125.81
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 415.17K
Average volume (90 days) 850.38K
Price summary
52-Week low 57.3
52-Week high 310
Beta -
50-Day moving average 194.24
200-Day moving average 141.41
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Mar 2026
Ex-Dividend Date 29 Dec 2025
Last split factor 53:50
Last split Date 8 Feb 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.49%
Operating margin -1.78%
Operational effectiveness
Return on assets -0.11%
Return on equity -0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.1
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.65
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 12.76
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 62.28%
Book value per share (mrq) 14.84
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
